Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest Expenses (2021 - 2025)

Kezar Life Sciences' Interest Expenses history spans 5 years, with the latest figure at $302000.0 for Q2 2025.

  • For Q2 2025, Interest Expenses fell 24.69% year-over-year to $302000.0; the TTM value through Sep 2025 reached $1.0 million, down 35.25%, while the annual FY2024 figure was $1.6 million, 2.77% up from the prior year.
  • Interest Expenses for Q2 2025 was $302000.0 at Kezar Life Sciences, down from $347000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $403000.0 in Q3 2024 and bottomed at $159000.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $370000.0 (2023), against an average of $342400.0.
  • The largest annual shift saw Interest Expenses surged 119.5% in 2022 before it decreased 24.69% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $159000.0 in 2021, then surged by 119.5% to $349000.0 in 2022, then increased by 14.33% to $399000.0 in 2023, then decreased by 2.51% to $389000.0 in 2024, then dropped by 22.37% to $302000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Interest Expenses are $302000.0 (Q2 2025), $347000.0 (Q1 2025), and $389000.0 (Q4 2024).